nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxycycline—SLC22A11—Methotrexate—ankylosing spondylitis	0.137	0.292	CbGbCtD
Doxycycline—SLC22A8—Methotrexate—ankylosing spondylitis	0.0795	0.17	CbGbCtD
Doxycycline—MMP13—synovial fluid—ankylosing spondylitis	0.0597	0.155	CbGeAlD
Doxycycline—SLC22A6—Methotrexate—ankylosing spondylitis	0.0554	0.118	CbGbCtD
Doxycycline—MMP13—knee—ankylosing spondylitis	0.0539	0.14	CbGeAlD
Doxycycline—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0486	0.104	CbGbCtD
Doxycycline—MMP1—synovial fluid—ankylosing spondylitis	0.042	0.109	CbGeAlD
Doxycycline—MMP13—skeletal joint—ankylosing spondylitis	0.0387	0.1	CbGeAlD
Doxycycline—MMP1—knee—ankylosing spondylitis	0.0379	0.0985	CbGeAlD
Doxycycline—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0369	0.0788	CbGbCtD
Doxycycline—CYP3A4—Betamethasone—ankylosing spondylitis	0.0316	0.0676	CbGbCtD
Doxycycline—CYP3A4—Prednisolone—ankylosing spondylitis	0.0312	0.0667	CbGbCtD
Doxycycline—CYP3A4—Prednisone—ankylosing spondylitis	0.0295	0.063	CbGbCtD
Doxycycline—MMP13—synovial membrane of synovial joint—ankylosing spondylitis	0.0294	0.0763	CbGeAlD
Doxycycline—MMP1—skeletal joint—ankylosing spondylitis	0.0272	0.0707	CbGeAlD
Doxycycline—MMP13—cartilage tissue—ankylosing spondylitis	0.026	0.0675	CbGeAlD
Doxycycline—MMP8—cartilage tissue—ankylosing spondylitis	0.0234	0.0609	CbGeAlD
Doxycycline—MMP1—synovial membrane of synovial joint—ankylosing spondylitis	0.0206	0.0537	CbGeAlD
Doxycycline—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0184	0.0393	CbGbCtD
Doxycycline—MMP1—cartilage tissue—ankylosing spondylitis	0.0183	0.0475	CbGeAlD
Doxycycline—MMP8—Matrix Metalloproteinases—MMP3—ankylosing spondylitis	0.00893	0.0605	CbGpPWpGaD
Doxycycline—MMP8—Activation of Matrix Metalloproteinases—MMP3—ankylosing spondylitis	0.00848	0.0575	CbGpPWpGaD
Doxycycline—MMP8—Collagen degradation—MMP3—ankylosing spondylitis	0.00739	0.0501	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—RUNX3—ankylosing spondylitis	0.00677	0.0458	CbGpPWpGaD
Doxycycline—MMP13—Matrix Metalloproteinases—MMP3—ankylosing spondylitis	0.00652	0.0442	CbGpPWpGaD
Doxycycline—MMP7—Matrix Metalloproteinases—MMP3—ankylosing spondylitis	0.00629	0.0426	CbGpPWpGaD
Doxycycline—MMP13—Activation of Matrix Metalloproteinases—MMP3—ankylosing spondylitis	0.00619	0.0419	CbGpPWpGaD
Doxycycline—MMP7—Activation of Matrix Metalloproteinases—MMP3—ankylosing spondylitis	0.00598	0.0405	CbGpPWpGaD
Doxycycline—MMP13—Collagen degradation—MMP3—ankylosing spondylitis	0.00539	0.0365	CbGpPWpGaD
Doxycycline—MMP7—Collagen degradation—MMP3—ankylosing spondylitis	0.00521	0.0353	CbGpPWpGaD
Doxycycline—MMP1—Matrix Metalloproteinases—MMP3—ankylosing spondylitis	0.00503	0.0341	CbGpPWpGaD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP3—ankylosing spondylitis	0.00498	0.0337	CbGpPWpGaD
Doxycycline—MMP1—Activation of Matrix Metalloproteinases—MMP3—ankylosing spondylitis	0.00478	0.0324	CbGpPWpGaD
Doxycycline—MMP13—tendon—ankylosing spondylitis	0.00444	0.0115	CbGeAlD
Doxycycline—MMP7—Posttranslational regulation of adherens junction stability and dissassembly—MMP3—ankylosing spondylitis	0.00432	0.0293	CbGpPWpGaD
Doxycycline—MMP13—Assembly of collagen fibrils and other multimeric structures—MMP3—ankylosing spondylitis	0.0042	0.0284	CbGpPWpGaD
Doxycycline—MMP1—Collagen degradation—MMP3—ankylosing spondylitis	0.00416	0.0282	CbGpPWpGaD
Doxycycline—MMP7—Assembly of collagen fibrils and other multimeric structures—MMP3—ankylosing spondylitis	0.00405	0.0275	CbGpPWpGaD
Doxycycline—MMP8—Degradation of the extracellular matrix—MMP3—ankylosing spondylitis	0.00374	0.0254	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—MMP3—ankylosing spondylitis	0.00351	0.0238	CbGpPWpGaD
Doxycycline—MMP7—p75(NTR)-mediated signaling—MMP3—ankylosing spondylitis	0.00323	0.0219	CbGpPWpGaD
Doxycycline—MMP8—Matrix Metalloproteinases—TNF—ankylosing spondylitis	0.0032	0.0217	CbGpPWpGaD
Doxycycline—MMP1—tendon—ankylosing spondylitis	0.00312	0.00812	CbGeAlD
Doxycycline—MMP13—Collagen formation—MMP3—ankylosing spondylitis	0.00286	0.0194	CbGpPWpGaD
Doxycycline—MMP7—Collagen formation—MMP3—ankylosing spondylitis	0.00276	0.0187	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—MMP3—ankylosing spondylitis	0.00273	0.0185	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—MMP3—ankylosing spondylitis	0.00271	0.0184	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—MMP3—ankylosing spondylitis	0.00264	0.0179	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—IL10—ankylosing spondylitis	0.0024	0.0163	CbGpPWpGaD
Doxycycline—MMP13—Matrix Metalloproteinases—TNF—ankylosing spondylitis	0.00233	0.0158	CbGpPWpGaD
Doxycycline—MMP7—Matrix Metalloproteinases—TNF—ankylosing spondylitis	0.00225	0.0153	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—HLA-A—ankylosing spondylitis	0.00212	0.0143	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—MMP3—ankylosing spondylitis	0.00211	0.0143	CbGpPWpGaD
Doxycycline—MMP1—Matrix Metalloproteinases—TNF—ankylosing spondylitis	0.0018	0.0122	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—MMP3—ankylosing spondylitis	0.00157	0.0106	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00122	0.00827	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—MMP3—ankylosing spondylitis	0.00114	0.00775	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—MMP3—ankylosing spondylitis	0.0011	0.00749	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00093	0.0063	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—MMP3—ankylosing spondylitis	0.000883	0.00599	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—B3GNT2—ankylosing spondylitis	0.000846	0.00573	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000777	0.00526	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—B3GNT2—ankylosing spondylitis	4.56e-05	0.000309	CbGpPWpGaD
